| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 140,135 | 68,714 | 69,535 | 74,881 | | Cost of Revenue | 7,754 | 7,367 | 9,320 | 11,416 | | | Gross Profit |
-
| 61,347 | 60,215 | 63,465 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 44,513 | 46,779 | 35,507 | 31,361 | | Non Recurring |
-
| (1,215) | 1,215 |
-
| | Others | 77,578 | 20,367 | 16,247 | 11,132 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| (4,584) | 7,246 | 20,972 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 10,290 | (4,584) | 7,246 | 20,972 | | Interest Expense | 5,519 | 5,265 | 5,361 | 6,324 | | Income Before Tax | 4,771 | (9,849) | 1,885 | 14,648 | | Income Tax Expense | 2,046 | (4,109) | 440 | 5,027 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,725 | (5,740) | 1,445 | 9,621 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,725 | (5,740) | 1,445 | 9,621 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,725 | ($5,740) | $1,445 | $9,621 |
|
0.03% Nasdaq 
0.48%
Income Statement
